Tom Meyers has over 20 years of experience representing the industry leaders in life science. He is internationally- recognized for his experience in creating, implementing and monetizing effective patent strategies. Tom leads the  Intellectual Property Group at Brown Rudnick and is the founder and  Co-Chair of the Firm’s multidisciplinary Life Sciences Group.

Tom represents public and private companies, investors, and academic institutions in the life sciences arena. His portfolio of life science companies spans diagnostics medical devices, life science tools and technology platforms, genomics, and therapeutics.

Before joining Brown Rudnick, Tom was a partner at Testa Hurwitz & Thibeault LLP and at  Cooley, LLP.  From 2004 – 2007, Tom served as Vice President and General Counsel of Helicos BioSciences Corporation, where he directed and implemented patent and legal strategies and played a significant role in that company’s IPO.

Tom speaks and writes extensively on patent and licensing matters, and presents frequently at major pharma and life sciences meetings. Tom is a leader in creating monetized barriers to entry and he is responsible for creating the foundational IP for a number of successful life sciences companies. Tom has served as an adjunct professor of law at Suffolk University Law School; and most-recently at MIT.



Developed and implemented patent strategy for numerous companies, resulting in IPOs, acquisitions, and licenses

Lead counsel in licensing transactions resulting successful M&A .

Negotiated and drafted numerous partnering deals, including a diagnostics company in $150+ million license deal.

Represented tools company in $10 million licensing transaction.

Developed patent strategy for leading non-invasive diagnostic for colorectal cancer.

Led numerous acquisitions of private companies by major public stategics.


Northwestern University School of Law – J.D., 1991

Bar Admissions

United States Court of Appeals for the Federal Circuit
Registered Patent Attorney, U.S. Patent and Trademark Office
“Intellectual Property Strategic Planning for Biotechnology Startups,” J. Biolaw & Business, Vol. 4 (2001)
“Patenting and Financing Bioinformatic Inventions,” Boston University Journal of Science Technology, Vol. 8 (2002)
“Patent Protection of Protein Structures and Databases,” Nature Structural Biology, Vol. 7 (2000)
“Field of Use Restrictions as Procompetitive Elements in Patent and Know-How License Agreements in the US and Europe,” Northwestern Journal of International Law & Business, Vol. 12 (1991), cited as one of the year’s best intellectual property articles and reprinted in Intellectual Property Law Review, Vol. 25 (1993)
Speaking Engagements
Panelist, "The Past, Present and Future of Gene Patenting," New York Biotechnology Association Annual Meeting, New York, New York (April 2010)
Update on Recent Pharma Cases in the U.S., HBM Partners Mountain Retreat (St. Moritz, Switzerland 2009)
Enterprise Risk Management Through IP Protection, BayBIO Breakfast Series (Palo Alto 2009)
Cross-Border Business: What You Need To Know, BioContact (Quebec City, Canada 2008)
Combining Patent and Business Strategies, MBC Entrepreneur’s University (Cambridge 2008)
Positioning Your Company for Long-Term Relationships: The Value of Effective Patent and Licensing Strategies, Windhover Therapeutic Partnerships (Philadelphia 2008)
Inconvenient Truths? Recent Patent Law Decisions and Their Impact on Partnering Deals, BioPartnering Europe (London, U.K. 2007)
Globalization Strategies for Emerging Corporates: Operationalizing Winning Strategies Citigroup Commercial Banking Group, Thought Leadership Roundtable (Mumbai, India 2006)
Lecturer, Making Effective Business Decisions Involving Intellectual Property and How to Protect and Preserve IP Assets, MCLE (2006)
Keynote speaker, UBS Global Pharmaceutical Conference (NYC 2000)
Lecturer, Development and Management of Your Patent Estate, MCLE (1998)
Professional Affiliations
Registered Patent Attorney, U.S. Patent and Trademark Office